Uninterrupted arousal is important for survival during threatening situations. Activation of 2 orexin/hypocretin neurons is implicated in sustained arousal. However, orexin neurons 3 produce and release orexin as well as several co-transmitters including dynorphin and 4 glutamate. Thus, it is important to disambiguate orexin peptide-dependent and 5 -independent physiological functions of orexin neurons. To attain this, we generated a 6 novel orexin-flippase (Flp) knock-in (KI) mouse line. Crossing with Flp-reporter or 7 Cre-expressing mice showed gene expression exclusively in orexin neurons.
Introduction 1
Orexin A (hypocretin-1) and orexin B (hypocretin-2) (de Lecea et al., 1998;  2 Sakurai et al., 1998) , generated from the same precursor protein called prepro-orexin, 3 are endogenous ligands for two closely related G-protein-coupled receptors termed 1 of orexin neurons. Although the phenotypic consequences of orexin neurons activation 2 in increased wakefulness was reinforced for by co-transmitters, these co-transmitters 3 rather deteriorated cataplexy. Together, these data clearly identified the importance of co-expressed orexin. However, while we counted 661 ± 15 dynorphin-positive 25 cells/animal, we did not find any orexin-positive neurons in the homozygous mice (n = 3 26 8 mice, Hetero vs Homo, p = 0.847 (dynorphin), p = 2.4e-5 (orexin), unpaired t-test),
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showing that the number of dynorphin-positive cells were comparable to that in 2 heterozygous animals. These immunohistochemical studies confirmed that orexin 3 neurons in homozygous mice did not express orexin, however, expression of dynorphin 4 was unaffected.
6
Electrophysiological properties of orexin neurons lacking orexin 7
The expression of EGFP in the OF mice allowed us to visualize orexin neurons in the 8 acute brain slice preparations. To this end, we sought to evaluate the importance of 9 orexin neuropeptides in conserving the electrophysiological properties of orexin 10 neurons. Therefore, we recorded and compared resting membrane potentials (Vrest),
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firing frequency, input resistance and capacitance in OF (KI/-), OF (KI/KI), and in the OF (KI/KI) mice were found to have significantly hyperpolarized membrane 14 potential (-58.8 ± 1.2 mV; n = 21) compared to OF (KI/-) mice (-51.6 ± 0.9 mV; n = 21, p = 15 1.0e-5) and OE mice (-50.4 ± 0.9 mV; n = 22, p = 3.5e-7; Figure 4A -i to 4A-iv).
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Spontaneous firing frequency measured by cell-attached recordings were also found to 17 be significantly lower in orexin neurons in OF (KI/KI) mice (1.5 ± 0.2 Hz; n = 25) 18 compared to OF (KI/-) mice (2.5 ± 0.3 Hz; n = 21, p = 0.015) and OE mice (2.6 ± 0.2 Hz;
19 n = 25, p = 0.004; Figure 4B -i to 4B-iv). This lower discharge rate could be attributed to 20 the hyperpolarized membrane potential of orexin neurons in homozygous mice. We next 21 measured the input resistance of identified neurons by measuring the voltage deviation 22 generated by current injection from -100 to +100 pA in the current clamp protocol. In mice 23 lacking orexin peptide (OF (KI/KI) mice), orexin neurons were found to have significantly 24 lower input resistance (485.9 ± 35.8 MΩ; n = 23) compared to OF (KI/-) mice (639.9 ± 25 48.2 MΩ; n = 21, p = 0.037) and OE mice (638.2 ± 43.4 MΩ; n = 24, p = 0.032; Figure  9 4C-i to 4C-iv). The lower input resistance in neurons lacking orexin peptides suggests 1 that greater synaptic inputs (current injection) are necessary to generate changes in 2 membrane potential. We also compared the membrane capacitance measured during 3 whole-cell recordings. Interestingly, we observed that orexin neurons in OF (KI/KI) mice 4 had significantly higher membrane capacitance (35.4 ± 1.3 pF; n = 25) than OF (KI/-) 5 mice (29.9 ± 1.5 pF; n = 25, p = 0.012) and OE mice (30.0 ± 1.3 pF; n = 25, p = 0.014, 6 one-way ANOVA post-hoc Tukey; Figure 4E ). This higher capacitance in orexin neurons 7 that lack orexin peptides reflects the increased surface area of the plasma membrane.
8
Taken together, these data clearly suggest that orexin neuropeptide is essential for 9 maintaining the active and passive electrophysiological properties of orexin neurons.
11
Orexin mediates feed-forward activation of orexin neurons via facilitation of 12 glutamatergic inputs
13
To characterize whether the excitatory and inhibitory synaptic inputs onto orexin neurons 14 are regulated by the presence or absence of orexin peptides, we recorded glutamatergic 15 and GABAergic inputs using the voltage clamp method. We recorded spontaneous 16 excitatory post-synaptic currents (sEPSCs) from EGFP-expressing orexin neurons in the 17 presence of picrotoxin (400 μM), a GABA-A receptor antagonist. We found that orexin 18 neurons lacking orexin protein had significantly lower sEPSC frequency while the 19 amplitudes were unaffected ( Figure 5A -5E). The average inter-event interval for all 20 recorded sEPSCs of orexin neurons in OF (KI/KI) mice was 247.2 ± 48.6 ms (n = 29) 21 while that of OF (KI/-) mice was 116.7 ± 7.6 ms (n = 25, p = 0.01 vs OF (KI/KI)) and OE 22 mice was 77.9 ± 7.4 ms (n = 26, p = 5.8e-4 vs OF (KI/KI), one-way ANOVA pot-hoc 23 Tukey; Figure 5D ). The sEPSC amplitude of orexin neurons in OF (KI/KI) mice was 22.6 24 ± 1.3 pA (n = 29) while that of OF (KI/-) mice was 22.6 ± 1.3 pA (n = 25, p = 1.0 OF (KI/KI)) 25 and in OE mice was 20.5 ± 1.1 pA (n = 26, p = 0.46 vs OF (KI/KI), one-way ANOVA 1 Next, we recorded spontaneous inhibitory post-synaptic currents (sIPSCs) 2 from orexin neurons in the presence of CNQX (20 μM) and AP-5 (50 μM) to block 3 glutamatergic inputs. Although sIPSCs in neurons lacking orexin peptides showed a 4 tendency toward decreasing frequency and amplitude, these changes were not 5 statistically significant. The inter-event interval for sIPSCs in orexin neurons in OF (KI/KI) 6 mice was 835.0 ± 124.6 ms (n = 17) while that of OF (KI/-) mice was 642.4 ± 70.9 ms (n 7 = 22, p = 0.35 vs OF (KI/KI)) and in OE mice was 595.0 ± 96.7 ms (n = 21, p = 0.21 vs OF 8 (KI/KI), one-way ANOVA post-hoc Tukey; Figure 5H ). The sIPSC amplitude in orexin 9 neurons in OF (KI/KI) mice was 48.4 ± 6.1 pA (n = 17) while that of OF (KI/-) mice was 10 52.5 ± 3.9 pA (n = 22, p = 0.86 vs OF (KI/KI)) and in OE mice was 57.7 ± 6.5 pA (n = 21, 11 p = 0.48 vs OF (KI/KI), one-way ANOVA post-hoc Tukey; Figure 5I ). Figure 6A ). We quantified the number of orexin-positive cells in every 4 th brain slices.
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The number of orexin-immunoreactive cells was 439 ± 23 cells/mouse in the brain of 11 heterozygous mice and, among these, 92.1 ± 0.6% expressed mCherry (n = 3 mice;
12 Figure 6B ). Moreover, a very similar number of LHA neurons expressed mCherry in both 13 heterozygous and homozygous mice: 422 ± 80 cells/mouse (n = 6) in OF (KI/-) and 455 ± 14 74 cells/mouse (n = 6) in OF (KI/KI) mice expressed mCherry (p = 0.76, unpaired t-test).
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To confirm the selective activation of hM3Dq-expressing neurons in vivo, we measured 16 the expression of an immediate early gene product, c-Fos, which is a surrogate 17 molecular marker of neuronal activity. Following the behavioral studies, 6 randomly 18 selected mice from both the heterozygous and homozygous groups received i.p.
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administration of either saline or clozapine N-Oxide (CNO) (1.0 mg/kg). Animals were 20 perfused, and tissues were collected 90 min after the injection. c-Fos staining of brain 21 slices confirmed that CNO selectively activated hM3Dq-expressing neurons in both 22 heterozygous and homozygous mice. In heterozygous mice, the ratio of c-Fos 23 expression in mCherry-positive cells of saline or CNO injected mice was 11.6 ± 1.9% or 24 89.2 ± 1.4%, respectively (n = 3 mice/group, p = 9.2e-5, Figure 6C -6D). In homozygous 25 mice, the ratio of c-Fos expression in mCherry-positive cells of saline or CNO injected 12 mice was 10.6 ± 1.8% or 90.3 ± 1.1%, respectively (n = 3 mice/group, p = 9.6e-4, paired 1 t-test, Figure 6C -6D). Thus, we concluded that the DREADD system successfully 2 enabled selective activation of orexin neurons in both heterozygous and homozygous 3 mice.
5
Orexin, and not other co-transmitters, was critical to promote sustained 6 wakefulness and preventing cataplexy 7
To this end, we compared the effect of chemogenetic activation of orexin neurons on 8 sleep/wakefulness. Mice were injected with either saline or CNO during the light (L) 9 period (at 10:00 AM) and the dark (D) period (at 10:00 PM; Figure 6E ). Expectedly in OF
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(KI/-) mice, activation of orexin neurons increased total time spent in wakefulness (n = 9, 11 Figure 
17
This clear difference could be explained by the ability of co-transmitters to 18 partially compensate for the increased wakefulness. Therefore, we hypothesized that the 19 co-transmitters could eventually rescue OF (KI/KI) mice from cataplexy as well.
20 Surprisingly, however, activation of orexin neurons that lacked orexin peptide rather activity manipulation to orexin neurons that lack orexin peptide using novel KI mice.
10
Previously, we generated orexin-Cre or orexin-tTA transgenic mice in which a short 3.2 11 kb fragment from the 5′-upstream region of the human prepro-orexin gene was used as a In agreement with this, we also found that orexin facilitated glutamate 8 release onto orexin neurons. However, several basic electrophysiological properties of 9 orexin neurons were also found to be altered in the absence of orexin peptides, including 10 hyperpolarized membrane potential, lower discharge rate and input resistance.
11 Surprisingly, the capacitance of orexin neurons that lack orexin peptide was significantly 12 larger than that of orexin neurons possessing orexin. This indicates that orexin neurons 9
On the contrary, we found that other behavioral outcomes of activating orexin 
24
The release of orexin follows a circadian rhythm that is also strongly related to 
7
In summary, here we dissociated the role of orexin at the cellular and 8 behavioral level. We suggest that the primary function of orexin is to maintain the 9 electrophysiological balance, the input-output functions in orexin neurons and most 10 importantly, to exert the function of orexin neurons in maintaining sustained wakefulness. Figure 1A ).
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The sequence of EGFP-2A-Flp was codon-optimized for expression in mammalian cells.
20
Linearized targeting vector was electroporated into embryonic stem cells from the Figure 6 ). CNO was dissolved in water to make a stock solution (10 mg/ml) and was diluted with saline to a 1 final concentration of 100 µg/ml just prior to i.p. administration.
2
EEG and EMG signals were amplified (AB-610J, Nihon Koden, Japan), filtered (EEG Co., Ltd., Japan) during both the light and dark periods. The dark period video recording 7 was assisted by infrared photography (Amaki Electric Co., Ltd., Japan) and an infrared 8 sensor (Kissei Comtec). EEG and EMG data were automatically scored in 4 sec epochs 9 and classified as wake, rapid eye movement sleep, and non-rapid eye movement sleep.
10
The EEG analysis yielded power spectra profiles over a 0~20 Hz window with 1 Hz 
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The p values were determined by a two-tailed student's t-test; data represent the mean ± 8 SEM. observed in either 24 hr or in the light or dark period in OF (KI/KI) mice (n = 7 5 mice). Values are represented as mean ± SEM.
